Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation

Breast Journal

Volumn 13, Issue 1, 2007, Pages 12-18

  Reddy, Shruthi G ^a   Kiel, Krystyna D ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

Breast cancer; Breast conserving surgery; Radiotherapy; Supraclavicular nodal failure

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SUPRACLAVICULAR LYMPH NODE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CLAVICLE; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILLINOIS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33845968809     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2006.00357.x     Document Type: Article

References (42)

1. Aberzik WJ, Silver B, Handerson IC, et al. The use of radiotherapy in patients with isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 1986;58:1214-18.
2. Andry G, Suciu S, Vice P, et al. Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol 1989;15:476-85.
3. Bedwinek JM, Feinberg B, Ocwieza M, et al. Analysis of failures following local treatment of isolated locoregional recurrence of breast cancer. Int J Radiat Oncol Biol Phys 1981;7:581-85.
4. Chen KK, Montague ED, Oswald MJ. Results of irradiation in treatment of locoregional breast cancer recurrence. Cancer 1985;56:1269-73.
5. Chu FC, Lin FJ, Kim JH, et al. Locally recurrent carcinoma of the breast: results of radiation therapy. Cancer 1976;37:2677-81.
6. Danoff BF, Coia LR, Cantor RI, et al. Locally recurrent breast carcinoma: the effect of adjuvant chemotherapy on prognosis. Radiology 1983;1147:849-52.
7. Deutsch M, Parsons JA, Mittal BB. Radiation therapy for local regional recurrent breast carcinoma. Int J Radiat Oncol Biol Phys 1986;12:2061-65.
8. Halverson KJ, Perez CA, Kuske RR, et al. Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1991;19:851-58.
9. Toonkel LN, Fix I, Jacobson LH, et al. The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 1985;3:660-65.
10. Adjuvant Therapy for Breast Cancer. NIH Consensus Statement Online 1-3 November 2000 [cited year, month, day]; 17, 1-23.
11. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer vz.2006. National Comprehensive cancer Network, Inc. Available at http://www.nccn.org. [Accessed November 16, 2006].
12. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539-69.
13. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10.
14. Van der Sangen MJC, Coebergh JW, Roumen RMH, et al. Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast cancer. Cancer 2003;98:11-18.
15. McKinna F, Gothard L, Ashley S, et al. Lymphatic relapse in women with early breast cancer: a difficult management problem. Eur J Cancer 1999;35:1065-69.
16. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-96.
17. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993;26:593-9.
18. Galper S, Recht A, Silver B, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157-66.
19. Chua B, Ung O, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J 2002;8:15-22.
20. Overgarrd M, Hansen PS, Overgarrd J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
21. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
22. Overgaard M, Jensen M, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999;353:1641-48.
23. Nielsen H, Overgaard M, Grau C, et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: longterm results from the Danish breast cancer cooperative group dbcg 82 b and c randomized studies. J Clin Oncol 2006;24: 2268-75.
24. Anonymous. Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 1998;158(Suppl. 3):S65-70.
25. Recht A, Gray R, Davidson N, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:1689-700.
26. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000;18:2817-27.
27. Goldhirsch A, Gelber RD, Castiglione M. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 1988;6:89-97.
28. Buzdar A, McNeese MD, Hortobagyi GN, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer 1990;65:394-99.
29. Kaufmann M, Jonat W, Abel U, et al. Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer. J Clin Oncol 1993;11:454-60.
30. Sykes HF, Sim DA, Wong CJ, et al. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989;16:641-47.
31. Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1337-47.
32. Chen S, Chen M, Hwang T, et al. Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int J Radiat Oncol Biol Phys 2002;52:614-19.
33. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001;19:1688-97.
34. Truong PT, Berthelet E, Lee J, et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103:2006-14.
35. Bozcuk H, Uslu G, Pestereli E, et al. Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators. Breast Cancer Res Treat 2001;68:239-48.
36. Whelan TJ. Use of conventional radiation therapy as part of breast-conserving treatment. J Clin Oncol 2005;23:1718-25.
37. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
38. Aristei C, Marsella AR, Chionne F, et al. Regional node failure in patients with four or more positive lymph nodes submitted to conservative surgery followed by radiotherapy to the breast. Am J Clin Oncol 2000;23:217-21.
39. Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four of more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003;56:658-70.
40. Fentiman IS, Lavelle MA, Caplan D, et al. The significance of supraclavicular fossa node recurrence after radical mastectomy. Cancer 1986;57:908-10.
41. Poortmans P, Kouloulias VE, Venselaar JL, et al. Quality assurance of EORTC trial 2922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur J Cancer 2003;39:2035-42.
42. Pritchard K, Whelan T. Clinical trial update: National Cancer Institute of Canada. Breast Cancer Res 2005;7:48-51.